Disposition of 95000 shares by Mva Investors, Llc of Tango Therapeutics at 8.68 subject to Rule 16b-3

TNGX Stock  USD 3.23  0.24  6.92%   
Slightly above 61% of Tango Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tango Therapeutics suggests that many traders are alarmed. Tango Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tango Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Tango Therapeutics Other: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at news.google.com
Google News at Macroaxis
  

Tango Therapeutics Fundamental Analysis

We analyze Tango Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tango Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tango Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Tango Therapeutics is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Tango Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tango Therapeutics stock to make a market-neutral strategy. Peer analysis of Tango Therapeutics could also be used in its relative valuation, which is a method of valuing Tango Therapeutics by comparing valuation metrics with similar companies.

Peers

Tango Therapeutics Related Equities

XLOXilio Development   12.00   
0%
87.0%
RLAYRelay Therapeutics   4.55   
0%
33.0%
NRIXNurix Therapeutics   3.23   
0%
23.0%
ARVNArvinas   2.01   
0%
14.0%
RVMDRevolution Medicines   0.20   
0%
1.0%
TYRATyra Biosciences   0.13   
0%
1.0%
EWTXEdgewise Therapeutics   0.08   
0%
1.0%
FHTXFoghorn Therapeutics   0.85   
6.0%
0%
KYMRKymera Therapeutics   0.98   
7.0%
0%
THRDThird Harmonic   1.55   
11.0%
0%
STTKShattuck Labs   3.15   
22.0%
0%
CNTBConnect Biopharma   3.45   
25.0%
0%
CGEMCullinan Oncology   3.72   
27.0%
0%
STOKStoke Therapeutics   3.76   
27.0%
0%
BDTXBlack Diamond   4.25   
30.0%
0%
RLYBRallybio Corp   4.76   
34.0%
0%
PLRXPliant Therapeutics   4.97   
36.0%
0%
PASGPassage Bio   5.71   
41.0%
0%
GLUEMonte Rosa   8.27   
60.0%
0%
RAPTRAPT Therapeutics   9.38   
68.0%
0%
MLYSMineralys Therapeutics,   13.71   
100.0%
0%

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.